Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Regulatory Toxicology and Pharmacology : RTP
|
August 2, 2011
Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program
Christopher J Borgert, Ellen M Mihaich, Lisa S Ortego, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 1, 2006
Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S
Richard A Becker, Christopher J Borgert, Simon Webb, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 22, 2016
Does GLP enhance the quality of toxicological evidence for regulatory decisions?
Christopher J Borgert, Richard A Becker, Betsy D Carlton, et al.
Toxicology Letters
|
January 7, 2021
Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology
Frank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
Toxicology Letters
|
April 27, 2021
Corrigendum to "Critique of the "Comment" etitled "Pyrethroid exposure: not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology"
Frank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Environmental Toxicology and Pharmacology
|
May 12, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Archives of Toxicology
|
April 8, 2023
US regulations to curb alleged cancer causes are ineffectual and compromised by scientific, constitutional and ethical violations
Gio B Gori, Michael Aschner, Christopher J Borgert, et al.
Journal of Toxicology and Environmental Health. Part A
|
June 20, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Regulatory Toxicology and Pharmacology : RTP
|
August 2, 2011
Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program
Christopher J Borgert, Ellen M Mihaich, Lisa S Ortego, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 1, 2006
Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S
Richard A Becker, Christopher J Borgert, Simon Webb, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 22, 2016
Does GLP enhance the quality of toxicological evidence for regulatory decisions?
Christopher J Borgert, Richard A Becker, Betsy D Carlton, et al.
Toxicology Letters
|
January 7, 2021
Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology
Frank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
Toxicology Letters
|
April 27, 2021
Corrigendum to "Critique of the "Comment" etitled "Pyrethroid exposure: not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology"
Frank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Environmental Toxicology and Pharmacology
|
May 12, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Archives of Toxicology
|
April 8, 2023
US regulations to curb alleged cancer causes are ineffectual and compromised by scientific, constitutional and ethical violations
Gio B Gori, Michael Aschner, Christopher J Borgert, et al.
Journal of Toxicology and Environmental Health. Part A
|
June 20, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Page
of 6